In the past week, GNLX stock has gone up by 18.44%, with a monthly gain of 20.42% and a quarterly surge of 2.85%. The volatility ratio for the week is 13.09%, and the volatility levels for the last 30 days are 8.72% for Genelux Corp The simple moving average for the past 20 days is 17.72% for GNLX’s stock, with a 7.01% simple moving average for the past 200 days.
Is It Worth Investing in Genelux Corp (NASDAQ: GNLX) Right Now?
Company’s 36-month beta value is -1.74.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GNLX is 30.04M, and currently, short sellers hold a 5.41% ratio of that floaft. The average trading volume of GNLX on January 22, 2025 was 139.68K shares.
GNLX) stock’s latest price update
Genelux Corp (NASDAQ: GNLX)’s stock price has soared by 17.48 in relation to previous closing price of 2.46. Nevertheless, the company has seen a gain of 18.44% in its stock price over the last five trading days. globenewswire.com reported 2024-12-13 that WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board will participate in a virtual fireside chat with H.C. Wainwright & Co. on December 16, 2024.
Analysts’ Opinion of GNLX
Many brokerage firms have already submitted their reports for GNLX stocks, with Guggenheim repeating the rating for GNLX by listing it as a “Buy.” The predicted price for GNLX in the upcoming period, according to Guggenheim is $8 based on the research report published on October 29, 2024 of the previous year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see GNLX reach a price target of $10. The rating they have provided for GNLX stocks is “Buy” according to the report published on August 28th, 2024.
H.C. Wainwright gave a rating of “Buy” to GNLX, setting the target price at $35 in the report published on November 27th of the previous year.
GNLX Trading at 12.07% from the 50-Day Moving Average
After a stumble in the market that brought GNLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.14% of loss for the given period.
Volatility was left at 8.72%, however, over the last 30 days, the volatility rate increased by 13.09%, as shares surge +26.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.56% lower at present.
During the last 5 trading sessions, GNLX rose by +18.44%, which changed the moving average for the period of 200-days by -40.53% in comparison to the 20-day moving average, which settled at $2.45. In addition, Genelux Corp saw 22.46% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GNLX starting from Tyree James L, who sale 3,460 shares at the price of $2.46 back on Dec 30 ’24. After this action, Tyree James L now owns 45,791 shares of Genelux Corp, valued at $8,512 using the latest closing price.
JAMES L TYREE, the Director of Genelux Corp, proposed sale 3,460 shares at $2.46 during a trade that took place back on Dec 30 ’24, which means that JAMES L TYREE is holding shares at $8,512 based on the most recent closing price.
Stock Fundamentals for GNLX
Current profitability levels for the company are sitting at:
- -19.67 for the present operating margin
- 0.56 for the gross margin
The net margin for Genelux Corp stands at -18.79. The total capital return value is set at -0.83. Equity return is now at value -96.85, with -74.41 for asset returns.
Based on Genelux Corp (GNLX), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -11.69. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -4824.83.
Currently, EBITDA for the company is -26.46 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 65.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.47.
Conclusion
In a nutshell, Genelux Corp (GNLX) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
